ASCO Issues Guidelines on HPV Vaccination Based on Available Resources — Physician’s First Watch

Medical News |
March 20, 2017

ASCO Issues Guidelines on HPV Vaccination Based on Available Resources

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

The American Society of Clinical Oncology has issued guidelines on human papillomavirus (HPV) vaccination according to the resources available in a patient's community.

Among the recommendations for females, published in the Journal of Global Oncology:

  • All resource settings: Two doses of HPV vaccine are recommended for those aged 9 to 14 years, with intervals ranging from 6 months to 12–15 months.

  • Maximal and enhanced settings: If girls are 15 or older and received their first vaccine dose before age 15, they may complete the vaccine series; if they weren't vaccinated before age 15, three doses should be given. Vaccination may occur through age 26.

  • Limited and basic settings: If there are adequate resources after fully vaccinating at least 50% of girls aged 9 to 14, girls who received only one dose may complete the vaccine series between ages 15 and 26.

The various levels of resource availability are defined in Table 1 of the guidelines. In addition, advice for vaccinating males is offered, as is guidance on vaccinating those with immunosuppression.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.